3-Nitro-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride
97%
- Product Code: 218209
CAS:
1354542-05-4
| Molecular Weight: | 215.64 g./mol | Molecular Formula: | C₈H₁₀ClN₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD16249529 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Store in an inert gas at room temperature |
Product Description:
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system agents and potential neuroprotective drugs. Its structure supports further functionalization for creating biologically active molecules. Commonly employed in research settings for designing novel heterocyclic compounds with therapeutic potential. Also utilized in the preparation of kinase inhibitors and other enzyme-targeting molecules in medicinal chemistry.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿3,800.00 |
+
-
|
| 250mg | 10-20 days | ฿7,610.00 |
+
-
|
3-Nitro-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system agents and potential neuroprotective drugs. Its structure supports further functionalization for creating biologically active molecules. Commonly employed in research settings for designing novel heterocyclic compounds with therapeutic potential. Also utilized in the preparation of kinase inhibitors and other enzyme-targeting molecules in medicinal chemistry.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :